WSTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
WEST PHARMACEUTICAL SERVICES INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 23, 2026
$383.91−0.11 (-0.03%)
Close on Oct 19, 2026
- Market cap
- $27.37B
- P/E (TTM)
- 49.2
- Dividend yield
- 0.22%
Debt
Borrowings on the balance sheet, Jun 30, 2026
Total debt
$202.90M
$0 due within a year
Net debt
-$232.90M
After $435.80M of cash
Implied interest rate
0.25%
FY2025 interest ÷ average debt
Interest coverage
1169.8×
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
Bond issues
Individual notes and bonds outstanding
Bond-level data is not connected yet
Coupon, maturity and amount of each note will come from the debt footnote in West Pharmaceutical Services's annual report. Trading prices and yields need FINRA TRACE data.